In ESRD, high serum phosphate levels, high fibroblast growth factor 23 (FGF23) levels and low serum Klotho levels are considered to play a role in cardiac hypertrophy and cardiac fibrosis. The gene discussed is FGF23; the disease is cardiac hypertrophy.